The number of people living with HIV in the Middle East and North Africa has risen to 460,000 and some 68,000 people were newly infected in 2006 alone. In a bid to curb the region?s growing epidemic, countries have been working with UNAIDS to secure additional funding to scale-up the AIDS response in the region.
Indian Health Minister Anbumani Ramadoss today warned protesting resident doctors of AIIMS that they may face action if they don’t call off the stir.
The U.S. Food and Drug Administration (FDA) today approved Celebrex (celecoxib) for a new use ? the relief of the signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) in patients two years of age and older. Today’s approval follows the November 29 meeting of FDA’s Arthritis Advisory Committee, in which the committee voted 15 to 1 in favor of approval of this product.
The Food and Drug Administration (FDA) today approved Cyanokit (containing the drug hydroxocobalamin, intravenous tubing and a sterile spike for reconstituting the drug product with saline) for the treatment of known or suspected cyanide poisoning. The approval, which is based on evidence of the drug’s effectiveness when tested in animals, improves the nation’s ability to respond to emergencies, including a potential attack by terrorists.
Postmenopausal women with early-stage, hormone-sensitive breast cancer have a lower risk of disease recurrence when their treatment includes a new class of hormone therapy drugs, yet one out five women prescribed the drugs may not take them regularly, according to a study conducted by researchers at Dana-Farber Cancer Institute and AstraZeneca Pharmaceuticals.
Based on results recently presented at the 2006 San Antonio Breast Cancer Symposium, researchers speculate that a sudden decrease in the incidence of breast cancer in 2003 may be due to a reduction in the use of postmenopausal hormone therapy.
An article published in the American Journal of Gastroenterology highlights the ongoing debate over whether testing is necessary prior to diagnosis and treatment of patients with fecal incontinence (FI), the involuntary discharge of bowel contents. FI sufferers deal with significant quality of life issues and their condition often remains undiagnosed.
Experts in a variety of psychological disciplines have authored articles addressing the present and future of clinical psychology. The articles appear in a special issue of Clinical Psychology: Science and Practice.
Scientific, technological and medical advances made in the past two decades are leading to more definitive diagnoses, earlier and more effective treatment options and better outcomes for patients suffering from a condition called acromegaly, according to an article published in today’s issue of the New England Journal of Medicine and authored by a specialist in endocrinology at Cedars-Sinai Medical Center.
The progress registered by the country in nuclear medicine have to be extended to the poor, Atomic Energy Commission Chairman Anil Kakodkar said today.